MYELOMA MVP
Live / Registered — Registered (as of 26 Nov 2019)
What this means for you
Registered since 26 Nov 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87920209
- Registration number
- 5921818
- Mark type
- Stylized text
- Filed
- 14 May 2018
- Published for opposition
- 19 Feb 2019
- Registered
- 26 Nov 2019
- Attorney of record
- Elsa D. Lemoine
Goods and services
- Class 035 — Advertising and business services: Promoting public awareness of health and medical issues; promoting public awareness of the dangers, diagnosis and treatment of blood disorders, cancers and multiple myeloma; promoting public awareness of the need to create plans to fight against blood disorders, cancers and multiple myeloma
Owner
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
Prosecution history
- 26 Nov 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 29 Apr 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 29 Apr 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Apr 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 29 Apr 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Apr 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Apr 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 26 Nov 2019 — REGISTERED-PRINCIPAL REGISTER
- 25 Oct 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Oct 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Oct 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Oct 2019 — USE AMENDMENT FILED
- 22 Oct 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Oct 2019 — TEAS STATEMENT OF USE RECEIVED
- 16 Apr 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT